Ontology highlight
ABSTRACT: Background
Despite considerable efforts toward vaccine development in past decades, no effective vaccines against respiratory syncytial virus (RSV) are available. Recently, we showed that an optimized formalin concentration can preserve prefusion protein (pre-F) on RSV-infected cells and protect mice against RSV infection without causing enhanced respiratory disease (ERD). Here, we sought to further stabilize pre-F on RSV virions by optimizing the production of FI-RSV.Methods
Freshly produced RSV virions were treated with formalin under different concentrations to obtained an opti-FI-RSV vaccine with high pre-F level. Immunogenicity and safety of opti-FI-RSV were evaluated in Balb/c mice and cotton rats.Results
Using 0.0156-0.1778% formalin, we successfully preserve
SUBMITTER: Lin M
PROVIDER: S-EPMC9612074 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature